Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 4 studies | 32% ± 6% | |
retinal cone cell | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 936.49 | 2583 / 2642 | 62% | 1.89 | 435 / 705 |
lung | 100% | 846.43 | 577 / 578 | 48% | 2.38 | 551 / 1155 |
esophagus | 82% | 192.09 | 1186 / 1445 | 58% | 6.43 | 106 / 183 |
uterus | 98% | 309.45 | 166 / 170 | 24% | 0.92 | 110 / 459 |
ovary | 98% | 281.51 | 176 / 180 | 22% | 0.40 | 96 / 430 |
breast | 100% | 346.03 | 458 / 459 | 14% | 0.48 | 156 / 1118 |
thymus | 100% | 519.11 | 651 / 653 | 9% | 0.23 | 54 / 605 |
kidney | 99% | 411.13 | 88 / 89 | 9% | 0.21 | 85 / 901 |
intestine | 96% | 259.60 | 928 / 966 | 7% | 0.12 | 39 / 527 |
spleen | 100% | 910.83 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2075.35 | 924 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 370.97 | 1193 / 1204 | 0% | 0 | 0 / 0 |
bladder | 81% | 246.95 | 17 / 21 | 18% | 0.58 | 90 / 504 |
prostate | 98% | 351.77 | 241 / 245 | 0% | 0.01 | 2 / 502 |
skin | 85% | 514.67 | 1545 / 1809 | 7% | 0.20 | 35 / 472 |
stomach | 82% | 167.77 | 296 / 359 | 10% | 0.16 | 28 / 286 |
adrenal gland | 82% | 201.00 | 211 / 258 | 4% | 0.12 | 10 / 230 |
blood vessel | 80% | 174.05 | 1065 / 1335 | 0% | 0 | 0 / 0 |
liver | 58% | 105.39 | 131 / 226 | 3% | 0.05 | 11 / 406 |
heart | 58% | 115.07 | 497 / 861 | 0% | 0 | 0 / 0 |
pancreas | 48% | 82.80 | 157 / 328 | 7% | 0.16 | 13 / 178 |
tonsil | 0% | 0 | 0 / 0 | 53% | 4.66 | 24 / 45 |
muscle | 21% | 37.51 | 167 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.18 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.11 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060294 | Biological process | cilium movement involved in cell motility |
GO_0036158 | Biological process | outer dynein arm assembly |
GO_0060285 | Biological process | cilium-dependent cell motility |
GO_0005930 | Cellular component | axoneme |
GO_0005874 | Cellular component | microtubule |
GO_0005858 | Cellular component | axonemal dynein complex |
GO_0036126 | Cellular component | sperm flagellum |
GO_0097729 | Cellular component | 9+2 motile cilium |
GO_0036157 | Cellular component | outer dynein arm |
GO_0030286 | Cellular component | dynein complex |
GO_0051959 | Molecular function | dynein light intermediate chain binding |
GO_0008569 | Molecular function | minus-end-directed microtubule motor activity |
GO_0045505 | Molecular function | dynein intermediate chain binding |
GO_0003777 | Molecular function | microtubule motor activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | DNAH17 |
Protein name | Dynein axonemal heavy chain 17 (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein axonemal light chain 2) Dynein axonemal heavy chain 17 |
Synonyms | DNEL2 DNAHL1 |
Description | FUNCTION: Force generating protein component of the outer dynein arms (ODAs) in the sperm flagellum. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP (Probable). Plays a major role in sperm motility, implicated in sperm flagellar assembly and beating . . |
Accessions | ENST00000591369.5 K7ELN3 Q9UFH2 ENST00000389840.7 [Q9UFH2-1] |